Christopher Edward, Poon Michael T C, Glancz Laurence J, Hutchinson Peter J, Kolias Angelos G, Brennan Paul M
College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.
Translational Neurosurgery, Centre for Clinical Brain Sciences, University of Edinburgh and Western General Hospital, Edinburgh, UK.
Neurosurg Rev. 2019 Jun;42(2):427-431. doi: 10.1007/s10143-018-0979-4. Epub 2018 Apr 21.
Increasing age and lower pre-operative Glasgow coma score (GCS) are associated with worse outcome after surgery for chronic subdural haematoma (CSDH). Only few studies have quantified outcomes specific to the very elderly or comatose patients. We aim to examine surgical outcomes in these patient groups. We analysed data from a prospective multicentre cohort study, assessing the risk of recurrence, death, and unfavourable functional outcome of very elderly (≥ 90 years) patients and comatose (pre-operative GCS ≤ 8) patients following surgical treatment of CSDH. Seven hundred eighty-five patients were included in the study. Thirty-two (4.1%) patients had pre-operative GCS ≤ 8 and 70 (8.9%) patients were aged ≥ 90 years. A higher proportion of comatose patients had an unfavourable functional outcome (38.7 vs 21.7%; p = 0.03), although similar proportion of comatose (64.5%) and non-comatose patients (61.8%) functionally improved after surgery (p = 0.96). Compared to patients aged < 90 years, a higher proportion of patients aged ≥ 90 years had unfavourable functional outcome (41.2 vs 20.5%; p < 0.01), although approximately half had functional improvement following surgery. Mortality risk was higher in both comatose (6.3 vs 1.9%; p = 0.05) and very elderly (8.8 vs 1.1%; p < 0.01) groups. There was a trend towards a higher recurrence risk in the comatose group (19.4 vs 9.5%; p = 0.07). Surgery can still provide considerable benefit to very elderly and comatose patients despite their higher risk of morbidity and mortality. Further research would be needed to better identify those most likely to benefit from surgery in these groups.
年龄增长和术前格拉斯哥昏迷评分(GCS)降低与慢性硬膜下血肿(CSDH)手术后较差的预后相关。仅有少数研究对高龄或昏迷患者的特定预后进行了量化。我们旨在研究这些患者群体的手术预后。我们分析了一项前瞻性多中心队列研究的数据,评估了高龄(≥90岁)患者和昏迷(术前GCS≤8)患者在接受CSDH手术治疗后的复发风险、死亡风险和不良功能预后。该研究共纳入785例患者。32例(4.1%)患者术前GCS≤8,70例(8.9%)患者年龄≥90岁。昏迷患者不良功能预后的比例更高(38.7%对21.7%;p = 0.03),尽管昏迷患者(64.5%)和非昏迷患者(61.8%)术后功能改善的比例相似(p = 0.96)。与年龄<90岁的患者相比,年龄≥90岁的患者不良功能预后的比例更高(41.2%对20.5%;p < 0.01),尽管约一半患者术后功能有所改善。昏迷组(6.3%对1.9%;p = 0.05)和高龄组(8.8%对1.1%;p < 0.01)的死亡风险均更高。昏迷组有复发风险更高的趋势(19.4%对9.5%;p = 0.07)。尽管高龄和昏迷患者的发病和死亡风险较高,但手术仍可为他们带来相当大的益处。需要进一步研究以更好地确定这些群体中最可能从手术中获益的患者。